Deere & Company’s PDL BioPharma, Inc. PDLI Stock Holding History

Deere & Company’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-306,917	Closed	-$1.54M	–	1091
2015 Q3	$1.54M	Buy	+306,917	New	+$1.76M	0.1%	262
2015 Q2	–	Sell	-263,802	Closed	-$1.86M	–	1194
2015 Q1	$1.86M	Buy	+263,802	New	+$1.91M	0.1%	246
2014 Q1	–	Sell	-195,241	Closed	-$1.65M	–	1166
2013 Q4	$1.65M	Buy	195,241 +169,350	+654%	+$1.43M	0.08%	229
2013 Q3	$206K	Hold	25,891	–	–	0.01%	900
2013 Q2	$200K	Buy	+25,891	New	+$202K	0.01%	869

Other funds holding PDLI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

GAM

Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Deere & Company's PDLI Position: Q4 2015 in Review

Deere & Company sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 306,917 shares — an estimated $1.54M sold.

Deere & Company first reported a position in PDLI in Q2 2013 and held it in 5 quarters. The position peaked at $1.86M in Q1 2015. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

Deere & Company reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
Deere & Company sold 306,917 PDL BioPharma, Inc. shares in Q4 2015, an estimated $1.54M.
Deere & Company first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 5 quarters.
Deere & Company's PDL BioPharma, Inc. position peaked at $1.86M in Q1 2015.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Deere & Company's 13F filing for Q4 2015, filed 10 Feb 2016.